Group 1 - The core viewpoint of the articles emphasizes the importance of nurturing "patient capital" to support hard technology research and development, highlighting the need for long-term investment strategies that align with the high-risk, high-reward nature of technological innovation [1][2][3] - The recent launch of the "Nuximon" software marks a significant step in building an independent industrial software ecosystem in China, showcasing advancements in various fields such as materials and technology applications [1] - The article discusses the necessity for investment institutions to develop a multi-track due diligence system that includes industry experts, ensuring that capital is effectively aligned with the technological needs of the industry [2] Group 2 - It is suggested that leading companies should actively leverage their capital to support smaller tech firms, creating opportunities for collaboration and reducing market risks for innovative technologies [2] - The concept of "risk laboratories" is introduced, where capital, research institutions, and enterprises can collaborate to explore cutting-edge technologies, sharing the burden of funding and the benefits of technology commercialization [2] - The articles stress that there are no shortcuts in the journey of technological innovation, advocating for a steadfast commitment to deep investment in core technologies and the transformation of industrial models and ecosystems [3]
以资本之“韧”筑科技之“基”
Zheng Quan Ri Bao·2026-01-27 16:25